Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
1.200
-0.080 (-6.25%)
At close: Nov 20, 2024, 4:00 PM
1.190
-0.010 (-0.83%)
After-hours: Nov 20, 2024, 7:04 PM EST
Atossa Therapeutics Market Cap
Atossa Therapeutics has a market cap or net worth of $150.96 million as of November 21, 2024. Its market cap has increased by 62.15% in one year.
Market Cap
150.96M
Enterprise Value
76.20M
1-Year Change
62.15%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since November 8, 2012, Atossa Therapeutics's market cap has increased from $62.00M to $150.96M, an increase of 143.49%. That is a compound annual growth rate of 7.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 151.00M | 36.90% |
Dec 29, 2023 | 110.30M | 64.87% |
Dec 30, 2022 | 66.90M | -66.98% |
Dec 31, 2021 | 202.60M | 197.94% |
Dec 31, 2020 | 68.00M | 375.52% |
Dec 31, 2019 | 14.30M | 146.55% |
Dec 31, 2018 | 5.80M | -17.14% |
Dec 29, 2017 | 7.00M | 32.08% |
Dec 30, 2016 | 5.30M | -45.36% |
Dec 31, 2015 | 9.70M | -72.36% |
Dec 31, 2014 | 35.10M | -16.03% |
Dec 31, 2013 | 41.80M | -17.06% |
Dec 31, 2012 | 50.40M | -18.71% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Greenwich LifeSciences | 167.86M |
2seventy bio | 166.11M |
The Joint | 164.07M |
Fulcrum Therapeutics | 162.36M |
Gossamer Bio | 161.71M |
Alpha Tau Medical | 160.83M |
Organigram Holdings | 159.62M |
Nevro | 158.88M |